Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Oral Health
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Biomarkers | Research

Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma

Authors: Kun Yue, Xue Yao

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

This study investigated a potential prognostic model based on telomere-related genes (TRGs) for the clinical prediction of oral squamous cell carcinoma (OSCC).

Methods

Gene expression data and associated clinical phenotypes were obtained from online databases. Differentially expressed (DE)-TRGs were identified between OSCC and normal samples, followed by protein-protein interaction and enrichment analyses. Subsequently, the prognostic genes explored based on the DE-TRGs and survival data were applied in the establishment of the current prognostic model, and an integrated analysis was performed between high- and low-risk groups using a prognostic model. The expression of certain prognostic genes identified in the present study was validated using qPCR analysis and/or western blot in OSCC cell lines and clinical samples.

Results

169 DE-TRGs were identified between the OSCC samples and controls. DE-TRGs are mainly involved in functions such as hypoxia response and pathways such as the cell cycle. Eight TRGs (CCNB1, PDK4, PLOD2, RACGAP1, MET, PLK1, KPNA2, and CCNA2) associated with OSCC survival and prognosis were used to construct a prognostic model. qPCR analysis and western blot showed that most of the eight prognostic genes were consistent with the current bioinformatics results. Analysis of the high- and low-risk groups for OSCC determined by the prognostic model showed that the current prognostic model was reliable.

Conclusions

A novel prognostic model for OSCC was constructed by TRGs. PLOD2 and APLK1 may participate in the progression of OSCC via responses to hypoxia and cell cycle pathways, respectively. TRGs, including KPNA2 and CCNA2, may serve as novel prognostic biomarkers for OSCC.
Appendix
Available only for authorised users
Literature
1.
2.
Troeltzsch M, Kunzel V, Haidari S, Troeltzsch M, Otto S et al. (2022) Desmoglein-3 overexpression in oral squamous cell carcinoma is associated with metastasis formation and early recurrence: an immunohistochemical study. J Cranio-Maxillofacial Surg: 50.
3.
Yedida G. (2012) Emerging Cell Therapies. Cell 2012.
4.
Lo W-L, Kao S-Y, Chi L-Y, Wong Y-K, Chang RC-S. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg. 2003;61:751–8.PubMedCrossRef
5.
Metzger K, Horn D, Pfeiffer T, Moratin J, Kansy K et al. (2019) Is panendoscopy a necessary staging procedure in patients with lacking risk factors and oral squamous cell carcinoma? J Cranio-Maxillofacial Surg: 47.
6.
Nelson CP, Codd V. Genetic determinants of telomere length and cancer risk. Curr Opin Genet Dev. 2020;60:63–8.PubMedCrossRef
7.
Pampalona J, Soler D, Genescà A, Tusell L. Telomere dysfunction and chromosome structure modulate the contribution of individual chromosomes in abnormal nuclear morphologies. Mutat Res. 2010;683:16–22.PubMedCrossRef
8.
Robles-Espinoza CD, Velasco-Herrera M, Hayward NK, Adams DJ. Telomere-Regulating genes and the Telomere Interactome in familial cancers. Cancer reviews; 2015.
9.
Banevicius M, Gedvilaite G, Vilkeviciute A, Kriauciuniene L, Zemaitiene R, et al. Association of relative leukocyte telomere length and genetic variants in telomere-related genes (TERT, TERT-CLPTM1, TRF1, TNKS2, TRF2) with atrophic age-related macular degeneration. Ophthalmic Genet. 2021;42:189–94.PubMedCrossRef
10.
11.
Picco V, Pages G, Benhamou, et al. The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma. Oral Oncol. 2016;57:46–53.PubMedCrossRef
12.
Padhi SS, Kar M, Saha A, Anuja K, Roy S et al. Interaction between the developmental genes and the telomeric shelterin complex-its prognostic implication in Head and neck squamous cell carcinoma.
13.
Varadi V, Brendle A, Brandt A, Johansson R, Enquist K, et al. Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. Eur J Cancer. 2009;45:3008–16.PubMedCrossRef
14.
Bulter KS, Griffith JK. Role of telomeric repeat binding factor 1 (TRF1) in Telomere maintenance and as a. Potential Prognostic Indicator in Human Breast Cancer; 2006.
15.
Simpson K, Jones RE, Grimstead JW, Hills R, Pepper C, et al. Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients. Mol Oncol. 2015;9:1186–93.PubMedPubMedCentralCrossRef
16.
JinWoo H, Chae-Ok Y. Telomere Gene Therapy. Polarizing Therapeutic Goals for Treatment of Various Diseases. Cells; 2019.
17.
Chang KP, Wang CI, Pickering CR, Huang Y, Tsai CN, et al. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma. Head Neck. 2017;39:1131–7.PubMedCrossRef
18.
Goldman MJ, Craft B, Hastie M, Repečka K, McDade F, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38:675–8.PubMedPubMedCentralCrossRef
19.
Edgar R, Domrachev M, Lash AE. Gene expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30:207–10.PubMedPubMedCentralCrossRef
20.
Smyth GK. limma: Linear Models for microarray data. In: Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York, NY: Springer New York; 2005. pp. 397–420.CrossRef
21.
von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, et al. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258–61.CrossRef
22.
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.PubMedPubMedCentralCrossRef
23.
Tang Y, Li M, Wang J, Pan Y, Wu FX. CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. BioSystems. 2015;127:67–72.PubMedCrossRef
24.
25.
Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein science: a publication of the Protein Society. 2019;28:1947–51.PubMedCrossRef
26.
Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587–92.PubMedCrossRef
27.
Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44.PubMedCrossRef
28.
Wang P, Wang Y, Hang B, Zou X, Mao JH. A novel gene expression-based prognostic scoring system to predict survival in gastric cancer. Oncotarget. 2016;7:55343–51.PubMedPubMedCentralCrossRef
29.
Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16:385–95.PubMedCrossRef
30.
Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18:248–62.PubMedCrossRef
31.
32.
Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739–40.PubMedPubMedCentralCrossRef
33.
Geeleher P, Cox N, Huang RS. pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE. 2014;9:e107468.PubMedPubMedCentralCrossRef
34.
Livak KJST. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))method. METHODS Dec. 2001;25(4):402–8.CrossRef
35.
Wang Y, Lin L, Xu H, Li T, Zhou Y, et al. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in chinese Han Population. J Oral Pathol Med. 2015;44:45–50.PubMedCrossRef
36.
Li G, Wang X, Liu G. PLOD2 is a potent prognostic marker and associates with Immune Infiltration in Cervical Cancer. Biomed Res Int. 2021;2021:5512340.PubMedPubMedCentral
37.
Gong X, Wang A, Song W. Clinicopathological significances of PLOD2, epithelial-mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma. Med (Baltim). 2022;101:e30112.CrossRef
38.
Sun Y, Wang S, Zhang X, Wu Z, Li Z et al. (2021) Identification and validation of PLOD2 as an adverse prognostic biomarker for oral squamous cell carcinoma. Biomolecules 11.
39.
Joseph JP, Harishankar MK, Pillai AA, Devi A. Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol. 2018;80:23–32.PubMedCrossRef
40.
Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar GD, Barros-Angueira F, Gándara-Rey JM, et al. Hypoxia-inducible factors in OSCC. Cancer Lett. 2011;313:1–8.PubMedCrossRef
41.
Okumura Y, Noda T, Eguchi H, Iwagami Y, Yamada D, et al. PLOD2 induced under hypoxia is involved in resistance to gemcitabine and poor prognosis in biliary tract cancer. Hepatology: Official Journal of the American Association for the Study of Liver Diseases; 2017. p. 66.
42.
Vittal K, Pandian SS, Joseph LD, Raj SG. Immunohistochemical expression of polo-like kinase 1 in oral squamous cell carcinoma and oral submucous fibrosis. Indian J Dent Res. 2018;29:171–5.PubMedCrossRef
43.
Sun EC, Dong SS, Li ZJ, Li CX. (2022) Clinicopathological Significance of AKT1 and PLK1 Expression in Oral Squamous Cell Carcinoma. Dis Markers 2022: 7300593.
44.
Kahl I, Mense J, Finke C, Boller AL, Lorber C, et al. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients. J Cell Biochem. 2022;123:581–600.PubMedCrossRef
45.
Jung Y, Kraikivski P, Shafiekhani S, Terhune SS, Dash RK. Crosstalk between Plk1, p53, cell cycle, and G2/M DNA damage checkpoint regulation in cancer: computational modeling and analysis. NPJ Syst Biol Appl. 2021;7:46.PubMedPubMedCentralCrossRef
46.
Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, et al. Survival outcomes after treatment of cancer of the oral cavity (1985–2015). Oral Oncol. 2019;90:115–21.PubMedPubMedCentralCrossRef
47.
Weber M, Lutz R, Olmos M, Glajzer J, Baran C et al. (2022) Beyond PD-L1-Identification of further potential therapeutic targets in oral Cancer. Cancers (Basel) 14.
48.
Chen J, Yang J, Li H, Yang Z, Zhang X, et al. Single-cell transcriptomics reveal the intratumoral landscape of infiltrated T-cell subpopulations in oral squamous cell carcinoma. Mol Oncol. 2021;15:866–86.PubMedPubMedCentralCrossRef
49.
Sasahira T, Kirita T. (2018) Hallmarks of Cancer-Related newly prognostic factors of oral squamous cell carcinoma. Int J Mol Sci 19.
50.
Huang GZ, Wu QQ, Zheng ZN, Shao TR, Lv XZ. Identification of candidate biomarkers and analysis of prognostic values in oral squamous cell carcinoma. Front Oncol. 2019;9:1054.PubMedPubMedCentralCrossRef
51.
52.
Kumari P, Kumar S, Sethy M, Bhue S, Mohanta BK, et al. Identification of therapeutically potential targets and their ligands for the treatment of OSCC. Front Oncol. 2022;12:910494.PubMedPubMedCentralCrossRef
53.
Li T, Liu D, Li C, Ru L, Wang X. Silencing of LncRNA AFAP1-AS1 inhibits cell proliferation in oral squamous Cancer by suppressing CCNA2. Cancer Manag Res. 2021;13:7897–908.PubMedPubMedCentralCrossRef
54.
55.
Lin F, Gao L, Su Z, Cao X, Zhan Y, et al. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Oncol Rep. 2018;40:179–94.PubMedPubMedCentral
Metadata
Title
Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma
Authors
Kun Yue
Xue Yao
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Biomarkers
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03157-x

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue

Case report

Endodontic management of maxillary first molar with protostylid: a rare case report

Research

Dental unit waterline testing practices: an 11-Year retrospective study

Research

Correlation between salivary cytokine profiles and white spot lesions in adolescent patients receiving clear aligner orthodontic treatment

Research

Association of oral care with periodontitis and glycemic control among US adults with diabetes

Research

Influence of buccal and palatal bone thickness on post-surgical marginal bone changes around implants placed in posterior maxilla: a multi-centre prospective study

Research

Application of entire dental panorama image data in artificial intelligence model for age estimation